LIDOX
Price
$11.79
Change
+$0.09 (+0.77%)
Updated
Jun 12 closing price
Net Assets
528.62M
TROZX
Price
$26.36
Change
+$0.17 (+0.65%)
Updated
Jun 12 closing price
Net Assets
16.71B
Interact to see
Advertisement

LIDOX vs TROZX

Header iconLIDOX vs TROZX Comparison
Open Charts LIDOX vs TROZXBanner chart's image
LIDOX vs TROZX Comparison Chart in %
View a ticker or compare two or three
VS
LIDOX vs. TROZX commentary
Jun 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIDOX is a Buy and TROZX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TROZX has more cash in the bank: 16.7B vs. LIDOX (529M). TROZX pays higher dividends than LIDOX: TROZX (2.95) vs LIDOX (2.70). LIDOX was incepted earlier than TROZX: LIDOX (9 years) vs TROZX (6 years). LIDOX (0.66) and TROZX (0.65) have similar cost to investors . LIDOX is a more actively managed with annual turnover of: 66.00 vs. TROZX (15.00). LIDOX (0) and TROZX (0) have matching initial minimum investment requirements. TROZX annual gain was more profitable for investors over the last year : 28.27 vs. LIDOX (25.23). TROZX return over 5 years is better than : 89.25 vs. LIDOX (56.10).
LIDOXTROZXLIDOX / TROZX
Total Expense Ratio0.660.00-
Annual Report Gross Expense Ratio0.660.65102%
Fund Existence9 years6 years-
Gain YTD10.39610.88196%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets529M16.7B3%
Annual Yield % from dividends2.702.9591%
Returns for 1 year25.2328.2789%
Returns for 3 years75.1988.6385%
Returns for 5 years56.1089.2563%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCO447.856.03
+1.36%
Moody's Corp
VLN2.21N/A
N/A
Valens Semiconductor Ltd
VCTR84.84-1.58
-1.83%
Victory Capital Holdings
APPS9.76-0.38
-3.75%
Digital Turbine
AKTX13.40-1.42
-9.58%
Akari Therapeutics Plc